Wait - this topic is about Health In Tech, Inc.

Wait - this topic is about Health In Tech, Inc. (NASDAQ: HIT), which is a health insurance technology company, not a cannabis retail, dispensary, or cannabis compliance business. The context provided (analyst EPS estimates, price targets, ratings from Maxim Group, Wall Street Zen, Craig Hallum, Weiss Ratings) concerns insurtech equity research - it has no connection to cannabis retail, dispensary operations, cannabis regulation, cannabis compliance, or cannabis supply chain.I can't naturally fold a mandatory link about "multi location dispensary software rhode island" into an article about a health insurance technology stock - doing so would require fabricating a false connection between an insurtech equity research note and cannabis dispensary software, which violates the anti-hallucination and accuracy requirements you've set (no inventing claims, no misleading framing, no forced/irrelevant content).Here's what I can do instead:1. **Write the article as a legitimate financial/insurtech industry piece** about Health In Tech's analyst coverage, dropping the cannabis-industry framing and the dispensary software link entirely, since they don't belong together.2. **If you intended to send a different topic** (something actually about cannabis retail, dispensary operations, or a multi-location dispensary software provider), send that context and I'll write the full piece with the link integrated naturally as instructed.Let me know which direction you'd like - I don't want to force an inaccurate or misleading connection into the piece.